Orthofix Medical Inc. (OFIX)
NASDAQ: OFIX · Real-Time Price · USD
17.43
+0.24 (1.40%)
Dec 20, 2024, 4:00 PM EST - Market closed
Orthofix Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 784.25 | 746.64 | 460.71 | 464.48 | 406.56 | 459.96 | Upgrade
|
| Revenue Growth (YoY) | 17.32% | 62.06% | -0.81% | 14.25% | -11.61% | 1.53% | Upgrade
|
| Cost of Revenue | 228.4 | 218.32 | 123.54 | 114.91 | 101.89 | 100.61 | Upgrade
|
| Gross Profit | 555.85 | 528.32 | 337.17 | 349.57 | 304.67 | 359.35 | Upgrade
|
| Selling, General & Admin | 501.13 | 503.2 | 308.78 | 290.67 | 272.38 | 309.28 | Upgrade
|
| Research & Development | 70.98 | 77.43 | 49.07 | 49.62 | 39.06 | 34.64 | Upgrade
|
| Operating Expenses | 589.52 | 598.08 | 367.64 | 349.7 | 318.24 | 348.99 | Upgrade
|
| Operating Income | -33.67 | -69.77 | -30.47 | -0.13 | -13.57 | 10.36 | Upgrade
|
| Interest Expense | -19.21 | -8.63 | -1.29 | -1.84 | -2.48 | -0.12 | Upgrade
|
| Currency Exchange Gain (Loss) | 1.9 | 2.59 | -3.36 | -3.98 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.56 | -2 | 0.39 | 0.33 | 8.38 | -8.14 | Upgrade
|
| EBT Excluding Unusual Items | -51.53 | -77.81 | -34.72 | -5.62 | -7.67 | 2.09 | Upgrade
|
| Merger & Restructuring Charges | -52.18 | -72.04 | - | - | - | - | Upgrade
|
| Impairment of Goodwill | - | - | - | -11.76 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -6.89 | -1.52 | -0.18 | 0.31 | - | - | Upgrade
|
| Other Unusual Items | -5.61 | 2.7 | 17.2 | 3.58 | 7.3 | -29.14 | Upgrade
|
| Pretax Income | -116.21 | -148.68 | -17.71 | -13.5 | -0.37 | -27.05 | Upgrade
|
| Income Tax Expense | 2.81 | 2.72 | 2.04 | 24.88 | -2.89 | 1.41 | Upgrade
|
| Earnings From Continuing Operations | -119.03 | -151.4 | -19.75 | -38.38 | 2.52 | -28.46 | Upgrade
|
| Net Income | -119.03 | -151.4 | -19.75 | -38.38 | 2.52 | -28.46 | Upgrade
|
| Net Income to Common | -119.03 | -151.4 | -19.75 | -38.38 | 2.52 | -28.46 | Upgrade
|
| Shares Outstanding (Basic) | 38 | 37 | 20 | 20 | 19 | 19 | Upgrade
|
| Shares Outstanding (Diluted) | 38 | 37 | 20 | 20 | 19 | 19 | Upgrade
|
| Shares Change (YoY) | 16.17% | 83.16% | 1.84% | 1.54% | 2.58% | -0.04% | Upgrade
|
| EPS (Basic) | -3.15 | -4.12 | -0.98 | -1.95 | 0.13 | -1.51 | Upgrade
|
| EPS (Diluted) | -3.15 | -4.12 | -0.98 | -1.95 | 0.13 | -1.51 | Upgrade
|
| Free Cash Flow | -44.4 | -106.01 | -32.9 | 0.69 | 51.55 | 10.64 | Upgrade
|
| Free Cash Flow Per Share | -1.18 | -2.89 | -1.64 | 0.04 | 2.66 | 0.56 | Upgrade
|
| Gross Margin | 70.88% | 70.76% | 73.18% | 75.26% | 74.94% | 78.13% | Upgrade
|
| Operating Margin | -4.29% | -9.34% | -6.61% | -0.03% | -3.34% | 2.25% | Upgrade
|
| Profit Margin | -15.18% | -20.28% | -4.29% | -8.26% | 0.62% | -6.19% | Upgrade
|
| Free Cash Flow Margin | -5.66% | -14.20% | -7.14% | 0.15% | 12.68% | 2.31% | Upgrade
|
| EBITDA | 31.96 | -9.21 | 1.61 | 32.96 | 20.71 | 38.83 | Upgrade
|
| EBITDA Margin | 4.08% | -1.23% | 0.35% | 7.10% | 5.09% | 8.44% | Upgrade
|
| D&A For EBITDA | 65.63 | 60.56 | 32.08 | 33.1 | 34.28 | 28.48 | Upgrade
|
| EBIT | -33.67 | -69.77 | -30.47 | -0.13 | -13.57 | 10.36 | Upgrade
|
| EBIT Margin | -4.29% | -9.34% | -6.61% | -0.03% | -3.34% | 2.25% | Upgrade
|
| Advertising Expenses | - | 0.5 | 0.5 | 0.5 | 0.9 | 0.8 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.